Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.074 AUD | +1.37% | -1.33% | +7.25% |
04-17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
04-17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NEUROTECH INTERNATIONAL LIMITED | Other Biotechnology & Medical Research | +1.37% | -1.33% | +7.25% | +57.45% | +469.23% | 50.12M |
Technical Rankings Surperformance
- Stock Market
- Equities
- NTI Stock
- Charts Neurotech International Limited
- Comparison Chart